• A comparative evaluation of anti-tumor activity following oral and intravenous delivery of doxorubic...

• Rehan Farah

• Karim Md. Emranul, Ahemad Nafees, Shaikh Mohd. Farooq, Gupta Manish, Gan Siew Hua, Chowdhury Ez...

• Journal of Pharmaceutical Investigation   2022  Volume.52  No.6 787 ~ 804

• Iron oxide nanoparticles-loaded hydrogels for effective topical photothermal treatment of skin cance...

• Amatya Reeju

• Kim Do-Yeon, Min Kyoung-Ah, Shin Meong-Cheol

• Journal of Pharmaceutical Investigation   2022  Volume.52  No.6 775 ~ 785

• Intranasal administration of an aronia extract and carrageenan nanocomposite for the prevention of i...

• Lee Jang-Su

• Kim Kyoung-Sub, Na Kun

• Journal of Pharmaceutical Investigation   2022  Volume.52  No.6 765 ~ 774

• Catalase-mimicking synthetic nano-enzymes can reduce lipopolysaccharide-induced reactive oxygen gene...

• Revuri Vishnu

• Mondal Jagannath, Mohapatra Adityanarayan, Rajendrakumar Santhosh Kalash, Surwase Sachin S., Park In...

• Journal of Pharmaceutical Investigation   2022  Volume.52  No.6 749 ~ 764

• Impact of buffer concentration on the thermal stability of immunoglobulin G

• Kim Soo-Hyun

• Yoo Han-Ju, Park Eun-Ji, Lee Won-Hwa, Na Dong-Hee

• Journal of Pharmaceutical Investigation   2022  Volume.52  No.6 739 ~ 747

• Tumor-originated pH-responsive nanovaccine mixture to treat heterogeneous tumors

• Park Jae-Duk

• Lee Eun-Sol, Lee Eun-Seong

• Journal of Pharmaceutical Investigation   2022  Volume.52  No.6 725 ~ 737

• Controlled release and targeted drug delivery with poly(lactic-co-glycolic acid) nanoparticles: revi...

• Zeb Alam

• Gul Maleeha, Nguyen Thi-Thao-Linh, Maeng Han-Joo

• Journal of Pharmaceutical Investigation   2022  Volume.52  No.6 683 ~ 724

• Quality by Design (QbD) application for the pharmaceutical development process

• Lee Sang-Ho

• Kim Jin-Ki, Jee Jun-Pil, Jang Dong-Jin, Park Young-Joon, Kim Joo-Eun

• Journal of Pharmaceutical Investigation   2022  Volume.52  No.6 649 ~ 682